paid access
Primary cutaneous amyloidosis — case report
, 13
Affiliations- Klinika Dermatologii, Kliniczny Szpital Wojewódzki nr 1 im. F. Chopina w Rzeszowie
- Kliniczny Zakład Patomorfologii, Kliniczny Szpital Wojewódzki Nr 1 w Rzeszowie
- Zakład Dermatologii, Instytut Nauk Medycznych, Kolegium Nauk Medycznych, Uniwersytet Rzeszowski
paid access
Abstract
Amyloidosis refers to a group of diseases in which tissues and organs accumulate amyloid — a protein with an abnormal structure, which leads to impairment of their function. There are systemic forms of amyloidosis, involving the internal organs and skin, and cutaneous ones, where the disease process affects only the skin. Here, we present a case of a seventy-year-old woman diagnosed with primary cutaneous amyloidosis.
Abstract
Amyloidosis refers to a group of diseases in which tissues and organs accumulate amyloid — a protein with an abnormal structure, which leads to impairment of their function. There are systemic forms of amyloidosis, involving the internal organs and skin, and cutaneous ones, where the disease process affects only the skin. Here, we present a case of a seventy-year-old woman diagnosed with primary cutaneous amyloidosis.
Full Text:
Add to basket: 49.00 PLN
Keywords
amyloid; gammopathy; amyloidosis
About this articleTitle
Primary cutaneous amyloidosis — case report
Journal
Issue
Article type
Case report
Pages
126-129
Published online
2020-12-02
Page views
974
Article views/downloads
46
DOI
Bibliographic record
Forum Dermatologicum 2020;6(4):126-129.
Keywords
amyloid
gammopathy
amyloidosis
Authors
Kamila Jaworecka
Robert Kijowski
Elżbieta Ostańska
Piotr Mazur-Chromiak
Adam Reich
References (7)- Wechalekar A, Gillmore J, Hawkins P. Systemic amyloidosis. The Lancet. 2016; 387(10038): 2641–2654.
- Ruzicka T, Bruch-Gerharz D. Skrobiawice i hialinozy. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M. ed. Braun-Falco Dermatologia. Tom 4. Wydawnictwo Czelej, Lublin 2017: 1275–1284.
- Myślak M, Mazurkiewicz J. Amyloidoza nerek. Algorytm dla nefrologa. Forum Nefrol. 2017; 10: 100–107.
- Hazenberg B. Amyloidosis. Rheum Dis Clin North Am. 2013; 39(2): 323–345.
- Pepys M. Amyloidosis. Ann Rev Med. 2006; 57: 223–41.
- Desport E, Bridoux F, Sirac C, et al. Centre national de référence pour l’amylose AL et les autres maladies par dépôts d’immunoglobulines monoclonales. Al amyloidosis. Orphanet J Rare Dis. 2012; 7: 54.
- Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 2015; 10: 321–344.
